Wileman T E, Lennartz M R, Stahl P D
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2501-5. doi: 10.1073/pnas.83.8.2501.
Mannose-lactoperoxidase, a neoglycoprotein prepared by reaction of lactoperoxidase with cyanomethyl 1-thiomannoside, bound to alveolar macrophages at 4 degrees C (Kd = 5.8 X 10(-8) M) and was rapidly internalized at 37 degrees C (K uptake = 2 X 10(-8) M). Mannose-lactoperoxidase binding and uptake were blocked by yeast mannan, and mannose-lactoperoxidase inhibited uptake of 125I-labeled mannose-BSA (bovine serum albumin). Radioiodination of cells with surface-bound mannose-lactoperoxidase was carried out in the presence of glucose and glucose oxidase. A major polypeptide (175 kDa) was radioiodinated by this procedure. Iodination of the 175-kDa polypeptide appeared to be receptor-mediated, since it was blocked by the presence of yeast mannan. Specific iodination was absent from receptor-negative cells. To demonstrate that the 175-kDa species is a ligand-binding protein, cells were iodinated by the standard lactoperoxidase method. Washed cells were then allowed to bind mannose-BSA. Receptor-ligand complexes, prepared by detergent extraction, were passed over anti-BSA IgG affinity columns. Mannose, but not mannose 6-phosphate or galactose, eluted a radioactive protein from the column that migrated with an apparent molecular mass of 175 kDa on NaDodSO4/PAGE. Detergent extracts of crude membranes prepared from macrophage-enriched whole rabbit lung were adsorbed to mannose-Sepharose; the fraction obtained by elution with mannose contained two protein components of 175 and 55 kDa. Subsequent chromatography on N-acetylglucosamine-agarose yielded a single protein of 175 kDa. The 175-kDa polypeptide was shown to bind 125I-labeled mannose-BSA in a precipitation assay. This binding could be blocked with mannan or mannose-BSA. The results indicate that the cell-surface mannose receptor is a 175-kDa protein.
甘露糖 - 乳过氧化物酶是一种通过乳过氧化物酶与氰甲基 - 1 - 硫代甘露糖苷反应制备的新糖蛋白,在4℃时与肺泡巨噬细胞结合(解离常数Kd = 5.8×10⁻⁸ M),并在37℃时迅速内化(摄取常数K摄取 = 2×10⁻⁸ M)。甘露糖 - 乳过氧化物酶的结合和摄取被酵母甘露聚糖阻断,并且甘露糖 - 乳过氧化物酶抑制了¹²⁵I标记的甘露糖 - 牛血清白蛋白(BSA)的摄取。在葡萄糖和葡萄糖氧化酶存在的情况下,对表面结合有甘露糖 - 乳过氧化物酶的细胞进行放射性碘化。通过该程序对一种主要多肽(175 kDa)进行了放射性碘化。175 kDa多肽的碘化似乎是受体介导的,因为它被酵母甘露聚糖的存在所阻断。受体阴性细胞中不存在特异性碘化。为了证明175 kDa的物质是一种配体结合蛋白,通过标准的乳过氧化物酶方法对细胞进行碘化。然后将洗涤后的细胞与甘露糖 - BSA结合。通过去污剂提取制备的受体 - 配体复合物通过抗 - BSA IgG亲和柱。甘露糖,但不是甘露糖6 - 磷酸或半乳糖,从柱上洗脱了一种放射性蛋白,该蛋白在NaDodSO4 / PAGE上的表观分子量为175 kDa。从富含巨噬细胞的全兔肺制备的粗膜的去污剂提取物吸附到甘露糖 - 琼脂糖上;用甘露糖洗脱得到的级分包含175 kDa和55 kDa的两种蛋白质成分。随后在N - 乙酰葡糖胺 - 琼脂糖上进行色谱分析得到一种单一的175 kDa蛋白质。在沉淀试验中表明,175 kDa多肽能结合¹²⁵I标记的甘露糖 - BSA。这种结合可以被甘露聚糖或甘露糖 - BSA阻断。结果表明,细胞表面甘露糖受体是一种175 kDa的蛋白质。